Skip to main content

Peer Review reports

From: Post-progression treatment in cancer randomized trials: a cross-sectional study of trials leading to FDA approval and published trials between 2018 and 2020

Original Submission
2 Aug 2022 Submitted Original manuscript
25 Nov 2022 Reviewed Reviewer Report - Karolina Strzebonska
17 Jan 2023 Reviewed Reviewer Report
19 Feb 2023 Author responded Author comments - Timothée Olivier
Resubmission - Version 2
19 Feb 2023 Submitted Manuscript version 2
24 Feb 2023 Author responded Author comments - Timothée Olivier
Resubmission - Version 3
24 Feb 2023 Submitted Manuscript version 3
15 Mar 2023 Reviewed Reviewer Report - Karolina Strzebonska
19 Apr 2023 Reviewed Reviewer Report - Denis L Jardim
29 Apr 2023 Author responded Author comments - Timothée Olivier
Resubmission - Version 4
29 Apr 2023 Submitted Manuscript version 4
Publishing
4 May 2023 Editorially accepted
17 May 2023 Article published 10.1186/s12885-023-10917-z

You can find further information about peer review here.

Back to article page